CF
35
2
OKE
59
3
JNPR
49
6
EFX
66
5
EMR
39
2
AIZ
73
5
DUK
47
2
FIS
48
5
NWSA
76
9
LEG
13
2
BWA
64
3
ITW
59
3
PH
69
2
AME
59
2
PSA
38
3
FITB
60
2
SIG
70
-2
AES
61
-3
C
44
-2
WAT
59
4
CF
35
2
OKE
59
3
JNPR
49
6
EFX
66
5
EMR
39
2
AIZ
73
5
DUK
47
2
FIS
48
5
NWSA
76
9
LEG
13
2
BWA
64
3
ITW
59
3
PH
69
2
AME
59
2
PSA
38
3
FITB
60
2
SIG
70
-2
AES
61
-3
C
44
-2
WAT
59
4
Financhill
Back

Bioventus Quote, Financials, Valuation and Earnings

Unlock the Secret to Earning Monthly Income!

Limited spots act swiftly
Sell
42

BVS
Bioventus

Last Price:
3.98
Seasonality Move:
72.81%

7 Day Trial

ALL ACCESS PASS

$ 7

This trade could move overnight Thursday!

Access my free presentation on these overnight trades right here

Bioventus Price Quote

$3.98
+0.01 (+0.76%)
(Updated: May 4, 2024 at 6:11 AM ET)

Bioventus Key Stats

Sell
42
Bioventus (BVS) is a Sell
Day range:
$3.94 - $4.12
52-week range:
$0.90 - $6.08
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.49
P/B ratio:
1.46%
Volume:
53K
Avg. volume:
129.1K
1-year change:
324.46%
Market cap:
$253.4M
Revenue:
$512.3M
EPS:
$-2.51

How Much Does Bioventus Make?

  • How Much Are Bioventus's Sales Annually?
    BVS Revenues are $512.3M
  • How Much Profit Does Bioventus's Make A Year?
    BVS net income is -$156.2M

Is Bioventus Growing As A Company?

  • What Is Bioventus's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.08%
  • What Is Bioventus's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Bioventus Stock Price Performance

  • Did Bioventus Stock Go Up Last Month?
    Bioventus share price went down by -20.92% last month
  • Did BVS's Share Price Rise Over The Last Year?
    BVS share price rose by 324.46% over the past 1 year

What Is Bioventus 52-Week High & Low?

  • What Is Bioventus’s 52-Week High Share Price?
    Bioventus has traded as high as $6.08 over the past 52 weeks
  • What Is Bioventus’s 52-Week Low Share Price?
    Bioventus has traded as low as $0.90 over the past 52 weeks

Bioventus Price To Free Cash Flow

  • Is Bioventus Stock Overvalued?
    Bioventus is trading at a price to free cash flow ratio of 31.16
  • Is Bioventus Stock Undervalued?
    Bioventus EV to Free Cash Flow ratio is 82.54
  • What Is Bioventus’s Price Earnings Growth Ratio?
    BVS PEG ratio is 0.00
  • Is Bioventus Trading At A Premium To Earnings?
    Bioventus EV to EBIT ratio is 0.00

Is It Risky To Buy Bioventus?

  • How Much Debt Does Bioventus Have?
    Total long term debt quarterly is $394.8M
  • How Much Cash Does Bioventus Have?
    Cash and short term investments quarterly total is $37M
  • What Is Bioventus’s Book Value Per Share?
    Book value per share is 2.74

Is Bioventus Cash Flow Positive?

  • What Is BVS Cash Flow From Operations?
    Cash flow from operations (TTM) is $15.3M
  • What Is Bioventus’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$26.7M
  • What Is Bioventus’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $15.8M

Bioventus Return On Invested Capital

  • Is Management Doing A Good Job?
    BVS return on invested capital is -23.16%
  • What Is Bioventus Return On Assets?
    ROA measures how assets are converting to revenues and is -16.55%
  • What Is BVS Return On Equity?
    ROE is a measure of profitability and is -58.58%

Bioventus Earnings Date & Stock Price

  • What Is Bioventus's Stock Price Today?
    A single share of BVS can be purchased today for 3.97
  • What Is Bioventus’s Stock Symbol?
    Bioventus trades on the nasdaq under the ticker symbol: BVS
  • When Is Bioventus’s Next Earnings Date?
    The next quarterly earnings date for Bioventus is scheduled on May 7, 2024
  • When Is BVS's next ex-dividend date?
    Bioventus's next ex-dividend date is May 5, 2024
  • How To Buy Bioventus Stock?
    You can buy Bioventus shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

Bioventus Competitors

  • Who Are Bioventus's Competitors?
    Below is a list of companies who compete with Bioventus or are related in some way:
    • Asensus Surgical Inc (ASXC)
    • Perspective Therapeutics Inc (CATX)
    • Retractable Technologies Inc (RVP)
    • Catheter Precision Inc (VTAK)
    • Xtant Medical Holdings Inc (XTNT)

Bioventus Dividend Yield

Data Unavailable

Bioventus Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 225.58%
Revenue: 7.62% 9.25%

Analyst Recommendations

Buy Recommendations: 2
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 8.00
Upside from Last Price: 101.51%

Major Shareholders

  • How many BVS shares are owned by institutional investors?
    37.8M BVS shares are owned by institutional investors
  • How many BVS shares are owned by insiders?
    3.8M BVS shares are owned by insiders